A psychedelic-rich alkaloid fraction obtained from Mimosa tenuiflora (Willd.) Poir attenuates somatic and affective symptoms of naloxone-precipitated morphine withdrawal in C57BL/6 mice.
Tiago R Da Silva, Keyla L B Machado, Isac M M Carvalho, Dayane C De Sousa, Fernanda D De M Campos, Giovanna O Da Silva, Guilherme A M Da L de Oliveira, Renato P De Sousa, Francisco M De S Silva, Fabrício P De M Do Amaral, Ciro G E Sá, Victor De J S Meireles, Luciano Da S Lopes, João Sammy N De Souza, Paulo J De O C Fortes, Lívio César C Nunes, Maurício P De M Do Amaral
Journal of Ethnopharmacology November 3, 2026 DOI: 10.1016/j.jep.2026.122602 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Animal experiment (preclinical study in mice) Peer reviewed |
|---|---|
| Population | Male C57BL/6 mice made morphine-dependent via a dose-escalation regimen, with withdrawal precipitated by naloxone |
| Interventions | Morphine Naloxone |
| Dose | AF II 3, 6, or 9 mg/kg, s.c. |
| Measures | Acetic acid-induced writhing test, open field test, somatic withdrawal signs (jumping, paw tremor, Walk in reverse) |
| Keywords | Mimosa tenuiflora Morphine Opioid withdrawal Psychedelics |
| Key findings | An alkaloid fraction (AF II) from Mimosa tenuiflora root bark reduced key somatic signs of naloxone-precipitated morphine withdrawal in mice, decreasing jumping and paw tremor without affecting "Walk in reverse," and increased exploratory behavior in the open field while modulating anxiety-related parameters. AF II did not interfere with morphine-induced analgesia. The authors conclude AF II selectively attenuates somatic and affective components of opioid withdrawal without compromising analgesia and support its potential as a preliminary candidate for acute opioid withdrawal modulation. |
Abstract
Mimosa tenuiflora (Willd.) Poir. root bark is traditionally used in northeastern Brazil to prepare "Jurema wine", a beverage employed to relieve emotional distress and restore psychological well-being. However, validating its traditional preparations in central substance withdrawal states remains underexplored. To evaluate the ethnopharmacological potential of M. tenuiflora, we investigated the effects of an alkaloid fraction (AF II) from its root bark on somatic and affective morphine withdrawal symptoms in mice, without compromising analgesia. Male C57BL/6 mice were used for the tests. Possible interference with morphine-induced analgesia was assessed using the acetic acid-induced writhing test. The animals were made morphine-dependent using a dose-escalation regimen, and withdrawal syndrome was precipitated with naloxone. AF II (3, 6, or 9 mg/kg, s.c.) was administered before withdrawal induction. AF II did not interfere with morphine analgesia. AF II significantly reduced key somatic signs of morphine withdrawal, decreasing jumping and paw tremor without affecting Walk in reverse. During withdrawal, AF II increased exploratory behavior in the open field and modulated anxiety-related parameters. The AF II from Mimosa tenuiflora, rich in serotonergic compounds, selectively attenuates somatic and affective components of opioid withdrawal in mice without compromising opioid analgesia, supporting its potential as a preliminary candidate for acute opioid withdrawal modulation. These findings provide scientific support for the traditional knowledge surrounding the central psychoactive and restorative properties of M. tenuiflora preparations.
Citations in the library
Cites 15
- Classical psychedelics for the treatment of depression and anxiety: A systematic review. Journal of Affective Disorders November 1, 2019
- Neuropharmacology of N,N-dimethyltryptamine Brain Research Bulletin April 30, 2016
- Agonist Properties of N,N-Dimethyltryptamine at Serotonin 5-HT2A and 5-HT2C Receptors Pharmacology, Biochemistry, and Behavior November 1, 1998
- Bufotenine: toward an understanding of possible psychoactive mechanisms. Journal of Psychoactive Drugs 2000
- Sustained effects of single doses of classical psychedelics in humans. Neuropsychopharmacology June 21, 2022
and 10 more in the library